OriGen Biomedical
Andre Ogundare is a seasoned financial analyst with extensive experience in reporting automation and financial modeling. Currently serving as Sr. Financial Analyst at OriGen Biomedical since April 2019, Andre excels in using SQL, Access, and Excel to create detailed reports and models that support strategic planning. Previously, Andre founded RamPath LLC and held key financial roles at CRH and Greenstream International, where contributions included developing production models and optimizing financial reporting processes. With a strong educational background, including an MBA in Finance from SMU Cox School of Business and a BA in Economics-Philosophy from Columbia University, Andre demonstrates a commitment to enhancing financial efficiency and reporting accuracy across various organizations.
This person is not in any teams
OriGen Biomedical
OriGen Biomedical, Inc. is a small, privately-held medical device manufacturer founded in 1997 and headquartered in Austin, Texas. They manufacture a range of products to treat respiratory distress, cancer, genetic conditions, and other life-threatening diseases.